Shareholder Class Action

     Shareholders accuse Schering Plough Corp. and its directors of securities violations – deceitful statements about its cholesterol drugs, Zetia and Vytorin – in Newark Federal Court.

      
     Shareholders sued Axcelis Technologies and its directors for rejecting Sumitomo Industries’ offer to buy Axcelis for $544 million, or $5.20 per share, in Delaware Chancery Court.